These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 26001635)

  • 1. Are patient-reported outcome instruments for ankylosing spondylitis fit for purpose for the axial spondyloarthritis patient? A qualitative and psychometric analysis.
    van Tubergen A; Black PM; Coteur G
    Rheumatology (Oxford); 2015 Oct; 54(10):1842-51. PubMed ID: 26001635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
    Osterhaus JT; Purcaru O
    Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
    van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
    Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis.
    Hoepken B; Serrano D; Harris K; Hwang MC; Reveille J
    Qual Life Res; 2021 Mar; 30(3):945-954. PubMed ID: 33128725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study.
    Landewé R; Braun J; Deodhar A; Dougados M; Maksymowych WP; Mease PJ; Reveille JD; Rudwaleit M; van der Heijde D; Stach C; Hoepken B; Fichtner A; Coteur G; de Longueville M; Sieper J
    Ann Rheum Dis; 2014 Jan; 73(1):39-47. PubMed ID: 24013647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis.
    He Q; Luo J; Chen J; Yang J; Yao C; Xu C; Tao Q
    Health Qual Life Outcomes; 2022 Jul; 20(1):116. PubMed ID: 35907948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test-retest reliability of outcome measures: data from three trials in radiographic and non-radiographic axial spondyloarthritis.
    Boel A; Navarro-Compán V; van der Heijde D
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34893536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and reliability of the ten-item Connor-Davidson Resilience Scale (CD-RISC10) instrument in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Ng A; Lim KK; Fong W; Phang JK; Chew EH; Lui NL; Tan CS; Thumboo J; Østbye T; Leung YY
    Rheumatol Int; 2019 Jan; 39(1):105-110. PubMed ID: 30523476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Certolizumab Pegol on Patient-Reported Outcomes in Patients With Axial Spondyloarthritis.
    Sieper J; Kivitz A; van Tubergen A; Deodhar A; Coteur G; Woltering F; Landewé R
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1475-80. PubMed ID: 25832312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and reliability of translation of the ASAS Health Index in a Colombian Spanish-speaking population with spondyloarthritis.
    Bautista-Molano W; Landewé RBM; Kiltz U; Valle-Oñate R; van der Heijde D
    Clin Rheumatol; 2018 Nov; 37(11):3063-3068. PubMed ID: 30259248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
    Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
    Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity Limitations in Patients with Axial Spondyloarthritis: A Role for Fear of Movement and (Re)injury Beliefs.
    Swinnen TW; Vlaeyen JWS; Dankaerts W; Westhovens R; de Vlam K
    J Rheumatol; 2018 Mar; 45(3):357-366. PubMed ID: 29142031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.
    Akgul O; Bodur H; Ataman S; Yurdakul FG; Capkin E; Gurer G; Sezer I; Duruoz MT; Melikoglu MA; Cay HF; Rezvani A; Yagci I; Gogus F; Kamanli A; Cevik R
    Rheumatol Int; 2020 Nov; 40(11):1793-1801. PubMed ID: 32814986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study.
    Dougados M; van der Heijde D; Tsai WC; Saaibi D; Marshall L; Jones H; Pedersen R; Vlahos B; Tarallo M
    Health Qual Life Outcomes; 2020 Jan; 18(1):4. PubMed ID: 31900174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Certolizumab pegol for treating axial spondyloarthritis.
    Desmarais J; Beier S; Deodhar A
    Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' perceptions of their ability to identify and refer patients with suspected axial spondyloarthritis: a qualitative study.
    van Onna M; Gorter S; van Meerendonk A; van Tubergen A
    J Rheumatol; 2014 May; 41(5):897-901. PubMed ID: 24692524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.